Stocks and Investing Stocks and Investing
Wed, May 4, 2022

Andrew Berens Maintained (AZN) at Buy with Increased Target to $75 on, May 4th, 2022


Published on 2024-10-27 20:49:44 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Increased Target from $70 to $75 on, May 4th, 2022.

Andrew has made no other calls on AZN in the last 4 months.



There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, all agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elmar Kraus of "DZ Bank" Upgraded from Strong Sell to Hold on, Friday, February 11th, 2022
Contributing Sources